指南与共识心脑血管急症重症综合管理与镇静镇痛

美国加速康复学会与围术期质量倡议联合共识:神经监测在围术期结局中的作用——脑近红外光谱

American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on the Role of Neuromonitoring in Perioperative Outcomes: Cerebral Near-Infrared Spectroscopy.
指南 / 共识 · Anesth Analg · 2020-01-01
一句话结论围术期脑氧饱和度监测应以麻醉诱导前基线值为参照解读,并审慎解读不同厂商数值;证据不足以推荐用于降低心脏手术后死亡或器官特异性并发症,也不足以推荐用于非心脏手术。

该共识由第六届围术期质量倡议(POQI-6)会议组织多学科国际专家组制定,采用GRADE标准评估脑氧饱和度监测文献。共识提出9条推荐:脑氧饱和度测量应参照诱导前基线值及影响其的生理变量解读;不同厂商设备数值不宜直接比较;术前及术中(以诱导前基线为参照)脑氧饱和度可用于识别心脏手术后不良结局风险增加的患者;可用于识别并指导心脏手术中急性脑灌注不良的处理;采用术中脑氧饱和度指导的干预算法可缩短心脏手术后ICU停留时间。但证据不足以推荐术中脑氧饱和度用于降低心脏手术后死亡率或器官特异性并发症,也不足以推荐用于改善非心脏手术结局。

要点

  • 围术期脑氧饱和度测量值应结合麻醉诱导前基线值及影响其的生理变量解读,而非孤立数值。
  • 不同厂商脑氧饱和度设备存在技术差异,数值不可互换,比较时应谨慎。
  • 术前及术中(以诱导前基线为参照)脑氧饱和度可用于识别心脏手术后不良结局风险增加的患者。
  • 脑氧饱和度可用于识别并指导心脏手术中急性脑灌注不良的处理。
  • 证据不足以推荐术中脑氧饱和度用于降低心脏手术后死亡率或器官特异性并发症,也不足以推荐用于非心脏手术。

适用人群与场景

  • 接受心脏手术的患者:术前及术中脑氧饱和度监测用于识别不良结局风险增加、识别并指导急性脑灌注不良处理、采用干预算法缩短ICU停留时间。
  • 接受非心脏手术的患者:证据不足以推荐术中脑氧饱和度用于改善结局。

处置流程与药物剂量

  • 解读围术期脑氧饱和度测量值时应参照麻醉诱导前基线值。
  • 解读围术期脑氧饱和度测量值时应结合影响其的生理变量。
  • 比较不同厂商的脑氧饱和度数值时应谨慎。
  • 术前使用脑氧饱和度识别心脏手术后不良结局风险增加的患者。
  • 术中脑氧饱和度以诱导前基线为参照,用于识别心脏手术后不良结局风险增加的患者。
  • 使用脑氧饱和度识别并指导心脏手术中急性脑灌注不良的处理。
  • 采用术中脑氧饱和度指导的干预算法以减少心脏手术后ICU停留时间。
  • 证据不足以推荐术中脑氧饱和度用于降低心脏手术后死亡率或器官特异性并发症。

研究设计与关键结果

  • 第六届围术期质量倡议(POQI-6)共识会议组织国际多学科专家(麻醉科、外科、重症医学科)系统调查脑氧饱和度文献,按GRADE标准形成9条共识推荐。
  • 推荐包括:以诱导前基线值解读围术期脑氧饱和度;结合影响脑氧饱和度的生理变量解读;比较不同厂商数值时谨慎;术前脑氧饱和度识别心脏手术后不良结局风险增加;术中脑氧饱和度以诱导前基线为参照识别心脏手术后不良结局风险增加;脑氧饱和度识别并指导心脏手术中急性脑灌注不良的处理;采用术中脑氧饱和度指导的干预算法缩短心脏手术后ICU停留时间。
  • 共识同时认为:证据不足以推荐术中脑氧饱和度用于降低心脏手术后死亡率或器官特异性并发症;证据不足以推荐术中脑氧饱和度用于改善非心脏手术后的结局。

证据类型、等级与局限

  • 证据类型:专家共识(共识会议),采用GRADE标准评估文献并形成推荐。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在心脏手术围术期,可依据诱导前基线值解读脑氧饱和度,结合影响其的生理变量,并谨慎比较不同厂商设备的数值。
  • 对心脏手术患者,术前及术中(以诱导前基线为参照)脑氧饱和度可用于识别不良结局风险增加;术中脑氧饱和度可用于识别并指导急性脑灌注不良的处理;采用术中脑氧饱和度指导的干预算法可缩短ICU停留时间。
  • 对心脏手术患者,不应基于现有证据推荐术中脑氧饱和度用于降低死亡率或器官特异性并发症;对非心脏手术患者,证据不足以推荐术中脑氧饱和度改善结局。

指南或共识出处

  • 美国加速康复学会与围术期质量倡议联合共识声明:神经监测在围术期结局中的作用——脑近红外光谱(Anesth Analg)

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Some neurological complications following surgery have been related to a mismatch in cerebral oxygen supply and demand that may either lead to more subtle changes of brain function or overt complications like stroke or coma. Discovery of a perioperative neurological complication may be outside the treatment window, thereby making prevention an important focus. Early commercial devices used differential spectroscopy to measure relative changes from baseline of 2 chromophores: oxy- and deoxyhemoglobin. It was the introduction of spatially resolved spectroscopy techniques that allowed near-infrared spectroscopy (NIRS)-based cerebral oximetry as we know it today. Modern cerebral oximeters measure the hemoglobin saturation of blood in a specific "optical field" containing arterial, capillary, and venous blood, not tissue oxygenation itself. Multiple cerebral oximeters are commercially available, all of which have technical differences that make them noninterchangeable. The mechanism and meaning of these measurements are likely not widely understood by many practicing physicians. Additionally, as with many clinically used monitors, there is a lack of high-quality evidence on which clinicians can base decisions in their effort to use cerebral oximetry to reduce neurocognitive complications after surgery. Therefore, the Sixth Perioperative Quality Initiative (POQI-6) consensus conference brought together an international team of multidisciplinary experts including anesthesiologists, surgeons, and critical care physicians to objectively survey the literature on cerebral oximetry and provide consensus, evidence-based recommendations for its use in accordance with the GRading of Recommendations, Assessment, Development and Evaluation (GRADE) criteria for evaluating biomedical literature. The group produced the following consensus recommendations: (1) interpreting perioperative cerebral oximetry measurements in the context of a preinduction baseline value; (2) interpreting perioperative cerebral oximetry measurements in the context of the physiologic variables that affect them; (3) using caution in comparing cerebral oximetry values between different manufacturers; (4) using preoperative cerebral oximetry to identify patients at increased risk of adverse outcomes after cardiac surgery; (5) using intraoperative cerebral oximetry indexed to preinduction baseline to identify patients at increased risk of adverse outcomes after cardiac surgery; (6) using cerebral oximetry to identify and guide management of acute cerebral malperfusion during cardiac surgery; (7) using an intraoperative cerebral oximetry-guided interventional algorithm to reduce intensive care unit (ICU) length of stay after cardiac surgery. Additionally, there was agreement that (8) there is insufficient evidence to recommend using intraoperative cerebral oximetry to reduce mortality or organ-specific morbidity after cardiac surgery; (9) there is insufficient evidence to recommend using intraoperative cerebral oximetry to improve outcomes after noncardiac surgery.

来源:Anesth Analg,查看原文。版权归原作者所有。

参考来源

  1. Thiele RH, Shaw AD, Bartels K, et al. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on the Role of Neuromonitoring in Perioperative Outcomes: Cerebral Near-Infrared Spectroscopy. Anesth Analg. 2020. PMID: 33079868. doi:10.1213/ANE.0000000000005081

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。